These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8185134)

  • 1. Apolipoprotein E in hyperlipidemia.
    Walden CC; Hegele RA
    Ann Intern Med; 1994 Jun; 120(12):1026-36. PubMed ID: 8185134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
    Weisgraber KH; Newhouse YM; Taylor JM; Tuan B; Nestruck AC; Davignon J; Mahley RW
    Arteriosclerosis; 1989; 9(1):50-7. PubMed ID: 2912421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
    Ghiselli G; Schaefer EJ; Gascon P; Breser HB
    Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH
    Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1).
    Steinmetz A; Assefbarkhi N; Eltze C; Ehlenz K; Funke H; Pies A; Assmann G; Kaffarnik H
    J Lipid Res; 1990 Jun; 31(6):1005-13. PubMed ID: 1973700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia.
    Richard P; de Zulueta MP; Beucler I; De Gennes JL; Cassaigne A; Iron A
    Atherosclerosis; 1995 Jan; 112(1):19-28. PubMed ID: 7772063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
    Moriyama K; Sasaki J; Matsunaga A; Arakawa F; Takada Y; Araki K; Kaneko S; Arakawa K
    Biochim Biophys Acta; 1992 Sep; 1128(1):58-64. PubMed ID: 1356443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
    Mann WA; Gregg RE; Sprecher DL; Brewer HB
    Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia.
    Hsia SH; Connelly PW; Hegele RA
    J Investig Med; 1995 Apr; 43(2):187-94. PubMed ID: 7735921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.
    Walden CC; Huff MW; Leiter LA; Connelly PW; Hegele RA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):699-704. PubMed ID: 7907341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.
    Evans D; Seedorf U; Beil FU
    Clin Genet; 2005 Oct; 68(4):369-72. PubMed ID: 16143024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoprotein E].
    Yamamura T
    Nihon Rinsho; 1994 Dec; 52(12):3124-32. PubMed ID: 7853700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E2/E2 genotype in combination with mutations in the LDL receptor gene causes type III hyperlipoproteinemia.
    Geisel J; Bunte T; Bodis M; Oette K; Herrmann W
    Clin Chem Lab Med; 2002 May; 40(5):475-9. PubMed ID: 12113291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
    Smelt AH; de Beer F
    Semin Vasc Med; 2004 Aug; 4(3):249-57. PubMed ID: 15630634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.